Desmopressin for Bleeding Related to Low Body Temperature
Status:
Unknown status
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
To study, with a prospective randomised controlled design, whether the subcutaneous
administration of the haemostatic drug desmopressin, may improve the impairment of primary
haemostasis due to mildly decreased temperature.